Pharma Pulse 4/19/24: The Real Cost of State Drug Importation Programs, Millions in Africa Will Miss HPV Shots After Merck Production Problem & more

News
Article

The latest news for pharma industry insiders.

Check out our coverage from LogiPharma Europe 2024

The Real Cost of State Drug Importation Programs? Patient Safety

Importing drugs from Canada may increase the risk of US citizens being exposed to unsafe medicines.

Talking About the Generations:The health and healthcare of boomers, Gen Xers, millennials and Gen Zers. Part 4, Gen Z.

Generation Z (1997–2012). Everything on demand, including healthcare.

Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem

The company has told countries that it can supply only 18.8 million of the 29.6 million doses it was contracted to deliver this year.

GE HealthCare Introduces AI-Enhanced Voluson Signature 20 and 18 Ultrasound Systems to Advance Women’s Health Imaging

GE HealthCare announced the launch of the Voluson Signature 20 and 18 ultrasound systems, which comprehensively integrate artificial intelligence, advanced tools and an ergonomic design to speed exam time for clinicians while delivering a clearer picture of various conditions impacting women’s health. These latest systems combine high-performance hardware with flexible scalable software to help increase clinicians’ confidence in their diagnostic and treatment determinations.

LogiPharma on LinkedIn:

Really interest insights from the panel, we hope to see you all again next year!

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs

© 2024 MJH Life Sciences

All rights reserved.